Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · IEX Real-Time Price · USD
0.761
-0.067 (-8.10%)
At close: Jul 19, 2024, 12:00 AM
0.780
+0.019 (2.46%)
Pre-market: Jul 22, 2024, 9:14 AM EDT
Cue Biopharma Employees
Cue Biopharma had 53 employees as of December 31, 2023. The number of employees increased by 1 or 1.92% compared to the previous year.
Employees
53
Change (1Y)
1
Growth (1Y)
1.92%
Revenue / Employee
$132,453
Profits / Employee
-$942,849
Market Cap
37.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
DarioHealth | 294 |
Precision Optics Corporation | 85 |
IceCure Medical | 77 |
Xilio Therapeutics | 73 |
Aligos Therapeutics | 66 |
Curis | 49 |
IN8bio | 31 |
CUE News
- 2 months ago - Cue Biopharma to Present at the 20th Annual PEGS Boston Summit - GlobeNewsWire
- 3 months ago - Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 3 months ago - Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights - GlobeNewsWire
- 5 months ago - Cue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium - GlobeNewsWire
- 8 months ago - Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit - GlobeNewsWire
- 9 months ago - Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November - GlobeNewsWire
- 9 months ago - Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms' Tumor 1 Positive Cancers at SITC 2023 - GlobeNewsWire
- 10 months ago - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - GlobeNewsWire